Ascendis Pharma A/S (FRA:A71)

Ascendis Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Market Capitalization	11,722	11,148	7,953	6,446	6,385	6,714
Market Cap Growth	57.78%	40.17%	23.38%	0.95%	-4.90%	-8.82%
Enterprise Value	11,977	11,422	8,129	6,647	6,035	5,870
Last Close Price	194.00	177.00	132.00	115.00	113.00	117.00
PS Ratio	16.28	15.48	21.87	24.17	124.77	863.17
PB Ratio	-72.00	-68.47	-75.24	-44.24	24.25	7.60
P/TBV Ratio	-	-	-	-	24.70	7.64
P/FCF Ratio	258.13	245.48	-	-	-	-
P/OCF Ratio	217.50	206.83	-	-	-	-
EV/Sales Ratio	16.69	15.86	22.35	24.92	117.92	754.73
EV/FCF Ratio	263.75	251.52	-	-	-	-
Debt / Equity Ratio	-5.35	-5.35	-8.10	-4.42	1.93	0.12
Debt / FCF Ratio	19.20	19.20	-	-	-	-
Net Debt / Equity Ratio	-1.57	-1.57	-2.81	-1.68	-0.89	-0.77
Net Debt / EBITDA Ratio	-1.95	-1.95	-1.08	-0.56	0.43	1.57
Net Debt / FCF Ratio	5.63	5.63	-0.97	-0.52	0.46	1.55
Asset Turnover	0.58	0.58	0.36	0.28	0.05	0.01
Inventory Turnover	0.32	0.32	0.18	0.26	0.12	-
Quick Ratio	0.72	0.72	0.81	0.62	1.06	7.03
Current Ratio	1.04	1.04	1.17	0.95	1.29	8.03
Return on Equity (ROE)	-	-	-	-818.43%	-101.69%	-44.54%
Return on Assets (ROA)	-6.86%	-6.86%	-17.38%	-29.73%	-32.29%	-27.35%
Return on Capital Employed (ROCE)	-58.40%	-58.40%	-102.60%	-511.40%	-150.60%	-45.90%
Earnings Yield	-1.95%	-2.05%	-4.75%	-7.47%	-9.13%	-5.71%
FCF Yield	0.39%	0.41%	-3.87%	-7.29%	-7.99%	-6.57%
Buyback Yield / Dilution	-4.69%	-4.69%	-2.85%	-0.38%	-2.37%	-8.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.